Daniela Gutiérrez Torres

Staff Scientist

National Heart Lung and Blood Institute
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (3)

INTRODUCTION: Evidence on the association between irritable bowel syndrome (IBS) and mortality is conflicting. In this study, we estimated the association between IBS and all-cause and cause-specific mortality in the NIH-AARP Diet and Health Study. METHODS: IBS diagnoses between 1994 and 2008 were identified from Medicare claims data, and mortality outcomes through 2019 were obtained through linkage to the National Death Index. Using multivariable Cox proportional hazards regression models, we estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for all-cause and cause-specific mortality within partitioned follow-up time categories (>2–5, >5–8, >8–11, >11–14, >14–17, and >17 years) with adjustment for confounders, including habitual diet and proxies for personal health advocacy/healthcare access. RESULTS: Of 132,697 individuals with available data, 5,030 (3.8%) had a prevalent IBS diagnosis. During the earliest follow-up interval (>2–5 years), the risk of all-cause mortality among individuals with IBS was 25% lower compared with those without IBS (HR = 0.75, 95% CI: 0.64–0.88), in the fully adjusted model. The inverse association attenuated over time such that during the >17-year follow-up interval, individuals with IBS had only an 8% lower risk of all-cause mortality (HR = 0.92, 95% CI: 0.87–0.98). Individuals diagnosed with IBS also had a lower risk of cancer and cardiovascular disease mortality, which attenuated over time. DISCUSSION: We found time-dependent inverse associations between IBS and all-cause, cancer and cardiovascular disease mortality. Although this association seemed to be strongly confounded by personal health advocacy/healthcare access during very short follow-up, further research is needed to explore the factors contributing to these associations observed after longer follow-up.

Year:

2026

Background Reducing cigarettes per day may lower the risk of lung cancer compared with continuing to smoke at the same intensity. Other changes in smoking behaviors, such as increasing cigarette consumption or quitting for a period and relapsing, may also affect lung cancer risk. Methods We examined changes in smoking status and cigarettes per day among 24 613 Finnish male smokers aged 50-69 years who participated in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Longitudinal data on smoking were collected during study follow-up visits 3 times a year (approximately every 4 months) between 1985 and 1993. Incident lung cancer patients through 2012 were identified by the Finnish Cancer Registry. Risk ratios (RRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards regression. Results Compared with smoking 20 cigarettes per day continuously across the intervention period, reducing an average of 5 cigarettes per day per year while smoking was associated with a 20% lower risk of lung cancer (95% CI = 0.71 to 0.90). A substantially lower risk of lung cancer was also observed when participants smoked at 50% (RR = 0.72, 95% CI = 0.57 to 0.90) and 10% (RR = 0.55, 95% CI = 0.36 to 0.83) of study visits, relative to smoked at 100% of study visits. Conclusions Smokers may lower their risk of lung cancer by reducing smoking intensity (cigarettes per day while smoking) and the time they smoke. However, quitting smoking completely is the most effective way for smokers to reduce their risk of lung cancer.

Year:

2024

Year:

2024

Collaborators (2)

Neal Freedman

Branch Chief

National Cancer Institute

UNITED STATES
View details

Carrie Daniel

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details